Home ›
Trademark Categories ›
Pharmaceuticals ›
2021 ›
DI ›
DIBETZA XR
Trademark search for:
DIBETZA XR
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-12-17 — Application filed
2021-12-21 — Application filed
2021-12-21 — Application filed
2022-09-22 — Assigned to examiner
2022-09-26 — Examiners amendment -written
2022-09-26 — Examiners amendment e-mailed
2022-09-26 — Notification of examiners amendment e-mailed
2022-09-26 — Examiner's amendment entered
2022-09-26 — Approved for pub - principal register
2022-10-12 — Notification of notice of publication e-mailed
2022-11-01 — Published for opposition
2022-11-01 — Official gazette publication confirmation e-mailed
2022-12-27 — Noa e-mailed - sou required from applicant
2023-01-23 — Teas change of correspondence received
2023-01-23 — Teas revoke/app/change addr of atty/dom rep received
2023-01-23 — Attorney/dom.rep.revoked and/or appointed
2023-05-30 — Sou teas extension received
2023-05-30 — Sou extension 1 filed
2023-05-30 — Sou extension 1 granted
2023-06-01 — Notice of approval of extension request e-mailed
2023-12-12 — Sou teas extension received
2023-12-12 — Sou extension 2 filed
2023-12-12 — Sou extension 2 granted
2023-12-14 — Notice of approval of extension request e-mailed
2024-06-07 — Sou teas extension received
2024-06-07 — Sou extension 3 filed
2024-06-07 — Sou extension 3 granted
2024-06-13 — Notice of approval of extension request e-mailed
2024-10-27 — Teas change of correspondence received
2024-10-27 — Teas withdrawal of attorney received-firm retains
2024-10-27 — Teas revoke/app/change addr of atty/dom rep received
2024-10-27 — Attorney/dom.rep.revoked and/or appointed
2024-10-30 — Sou teas extension received
2024-10-30 — Sou extension 4 granted
2024-10-30 — Notice of approval of extension request e-mailed
2024-10-30 — Sou extension 4 filed
2024-12-05 — Teas post publication amendment received
2025-06-27 — Case assigned to intent to use paralegal
2025-06-27 — Applicant/correspondence changes (non-responsive) entered
2025-07-28 — Application abandoned
2025-07-28 — Application abandoned
2025-07-28 — Final status recorded
Owner Information
Creekwood Pharmaceuticals LLC
Dover , DE
Creekwood Pharmaceuticals LLC
Dover , DE
Correspondent
Mike Rodenbaugh Rodenbaugh Law LLC 548 Market Street, Box 55819 San Francisco, CA 94104 United States
Filing Details
Filing Date:
2021-12-17
Status Date:
2025-07-28
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.